JP Morgan Chase
TAK icon

JP Morgan Chase’s Takeda Pharmaceutical TAK Stock Holding History

JP Morgan Chase’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-365,178
Closed -$7.44M – 6008
2019
Q1 		$7.44M Buy
+365,178
New +$7.35M ﹤0.01% 2283

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's TAK Position: Q1 2026 in Review

JP Morgan Chase increased its Takeda Pharmaceutical (TAK) stake by 87% in Q1 2026, buying an estimated $3.72M and bringing the position to 453,981 shares worth $8.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2851.

JP Morgan Chase first reported a position in TAK in Q4 2018 and has held it in 30 quarters since. 360 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • JP Morgan Chase held 453,981 shares of Takeda Pharmaceutical worth $8.29M as of Q1 2026.
  • JP Morgan Chase bought 211,802 Takeda Pharmaceutical shares in Q1 2026, an estimated $3.72M.
  • Takeda Pharmaceutical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2851 holding.
  • JP Morgan Chase first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 30 quarters since.
  • 360 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.